ReviewGenes & diseases2026
Selenoproteins: Minute yet vital players governing cellular fate.
Review in Genes & diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Selenotrisulfide delivery restores redox balance in myocardial infarction via a thiol-exchange reactionBioactive materials · 2026Article
- Article
- Strong Antiproliferative Activity Observed in Hammett-Guided Electronic Modulation of GPx-Mimetic Pathways in Aryl Selenoureas.International journal of molecular sciences · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Selenoproteins represent a distinct class of proteins that incorporate selenocysteine (Sec), whose biosynthesis and translational integration are dependent on selenium availability and the presence of a selenocysteine insertion sequence (SECIS). These proteins are indispensable for redox regulation, antioxidant defense, and thyroid hormone metabolism, among other vital biological processes. Remarkably, selenoproteins act as critical regulators of cellular fate decisions, a function that hinges on Sec-a residue whose biosynthesis and translational incorporation into protein involve machinery far more intricate than that of canonical amino acids. This evolutionary adaptation, whether arising from stochastic mutational events or as an obligatory trade-off for functional precision, underscores the sophisticated molecular regulatory strategies in living organisms. In this review, we comprehensively outline the uptake and metabolic pathways of selenoamino acids in eukaryotes, with particular emphasis on the biosynthetic mechanism of Sec and its unique translational incorporation into selenoproteins. We systematically elucidate the multi-layered regulatory networks that govern these biological processes within cells. Furthermore, we present a taxonomic classification and functional synthesis of eukaryotic selenoproteins, accompanied by an in-depth analysis of their molecular roles in various pathological states. Special emphasis is placed on the glutathione peroxidase (GPX) family, especially GPX4, in ferroptosis regulation and its sophisticated control mechanisms. Additionally, this review summarizes key challenges in current selenoproteins research and explores potential therapeutic strategies for cancer treatment by targeting selenoproteins.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.